Disulfiram (Tetraethylthiuram Disulfide) in the Treatment of Lyme Disease and Babesiosis: Report of Experience in Three Cases
Open accessAbstract
Three patients, each of whom had required intensive open-ended antimicrobial therapy for control of the symptoms of chronic relapsing neurological Lyme disease and relapsing babesiosis, were able to discontinue treatment and remain clinically well for periods of observation of 6-23 months following the completion of a finite course of treatment solely with disulfiram. One patient relapsed at six months and is being re-treated with disulfiram.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In 2019, three clinical instances introduced disulfiram as a potential treatment for chronic, relapsing tick-borne illnesses, initiating off-label use of disulfiram in Lyme disease.
“In 2019, three clinical instances were published, introducing DIS as a potential treatment for chronic, relapsing tick-borne illnesses,28 unintended initiating the off-label use of DIS in Lyme disease.”
From Off-label and repurposed use of disulfiram beyond alcohol dependence: A systematic review of clinical and preclinical evidence (2026) · cites this paper as [28]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Clostridium difficile infection
Smits, W. K., Lyras, D., Lacy, D. B., Wilcox, M. H., & Kuijper, E. J. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.20 · Cited by 886 · see citing works
Chronic Neurologic Manifestations of Lyme Disease
Logigian, E. L., Kaplan, R. F., & Steere, A. C. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011223232102 · Cited by 535 · see citing works
Atovaquone and Azithromycin for the Treatment of Babesiosis
Krause, P. J., Lepore, T. J., Sikand, V. K., Gadbaw, J. J., Burke, G., Telford, S. R., Brassard, P., Pearl, D., Azlanzadeh, J., Christianson, D., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432004 · Cited by 379 · see citing works
Concurrent Lyme Disease and Babesiosis
Krause, P. J. (1996) · JAMA · doi:10.1001/jama.1996.03530450047031 · Cited by 359 · see citing works
Persistent and Relapsing Babesiosis in Immunocompromised Patients
Krause, P. J., Gewurz, B. E., Hill, D. R., Marty, F. M., Vannier, E. G., Foppa, I., Furman, R. R., Neuhaus, E., Skowron, G., Gupta, S., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/525852 · Cited by 351 · see citing works
Firstenberg, M., Kornbau, C., Lee, K., & Hughes, G. C. (2015) · International Journal of Critical Illness and Injury Science · doi:10.4103/2229-5151.164940 · Cited by 335 · see citing works
CONCURRENT LYME DISEASE AND BABESIOSIS: EVIDENCE FOR INCREASED SEVERITY AND DURATION OF ILLNESS.
&NA; (1997) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199702000-00025 · Cited by 313 · see citing works
Persistent Parasitemia after Acute Babesiosis
Krause, P. J., Spielman, A., Telford, S. R., Sikand, V. K., McKay, K., Christianson, D., Pollack, R. J., Brassard, P., Magera, J. M., Ryan, R., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807163390304 · Cited by 289 · see citing works
A DRUG SENSITISING THE ORGANISM TO ETHYL ALCOHOL
Hald, J., & Jacobsen, E. (1948) · The Lancet · doi:10.1016/s0140-6736(48)91514-1 · Cited by 277 · see citing works
The Long-Term Clinical Outcomes of Lyme Disease: A Population-Based Retrospective Cohort Study
Shadick, N. A., Phillips, C. B., Logigian, E. L., Steere, A. C., Kaplan, R. F., Berardi, V. P., Duray, P. H., Larson, M. G., Wright, E. A., Ginsburg*, K. S., et al. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-8-199410150-00002 · Cited by 276 · see citing works
Disulfiram: An Old Therapeutic with New Applications
Barth, K. S., & Malcolm, R. J. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710790966678 · Cited by 271 · see citing works
IgM in microbial infections: Taken for granted?
Racine, R., & Winslow, G. M. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.06.003 · Cited by 269 · see citing works
Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness
Krause, P. J. (1996) · JAMA · doi:10.1001/jama.275.21.1657 · Cited by 266 · see citing works
Survival of Borrelia burgdorferi in antibiotically treated patients with lyme borreliosis
Preac‐Mursic, V., Wilske, B., Gross, B., Weber, K., Pfister, H.-W., Baumann, A., & Prokop, J. (1989) · Infection · doi:10.1007/bf01645543 · Cited by 225 · see citing works
The Actions and Metabolic Fate of Disulfiram
Eneanya, D. I., Bianchine, J. R., Duran, D. O., & Andresen, B. D. (1981) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.21.040181.003043 · Cited by 218 · see citing works
Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment
Straubinger, R. K., Summers, B. A., Chang, Y., & Appel, M. J. G. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.1.111-116.1997 · Cited by 218 · see citing works
Embers, M. E., Barthold, S. W., Borda, J. T., Bowers, L. C., Doyle, L. A., Hodzic, E., Jacobs, M. B., Hasenkampf, N. R., Martin, D. S., Narasimhan, S., et al. (2013) · PLoS ONE · doi:10.1371/annotation/f84663e3-0a2c-4243-8f97-3a58133c1b0f · Cited by 205 · see citing works
Zhang, Y., Wade, K. L., Prestera, T., & Talalay, P. (1996) · Analytical Biochemistry · doi:10.1006/abio.1996.0311 · Cited by 199 · see citing works
Inflammatory brain changes in Lyme borreliosis
Oksi, J., Kalimo, H., Marttila, R. J., Marjamäki, M., Sonninen, P. H., NIKOSKELAINEN, J., & Viljanen, M. K. (1996) · Brain · doi:10.1093/brain/119.6.2143 · Cited by 180 · see citing works
Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells
Sharma, B., Brown, A. V., Matluck, N. E., Hu, L. T., & Lewis, K. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00864-15 · Cited by 175 · see citing works
Kast, R. E., Boockvar, J. A., Brüning, A., Cappello, F., Chang, W., Cvek, B., Dou, Q. P., Dueñas‐González, A., Efferth, T., Focosi, D., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.969 · Cited by 168 · see citing works
Sharma, R., & Sharma, P. K. (2011) · Indian Journal of Ophthalmology · doi:10.4103/0301-4738.77035 · Cited by 159 · see citing works
Judith Miklossy, A., Kasas, S., Zurn, A. D., McCall, S. A., Yu, S. Y., & McGeer, P. L. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-40 · Cited by 156 · see citing works
Posttreatment Lyme Disease Syndrome
Aucott, J. N. (2015) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.02.012 · Cited by 154 · see citing works
Ma, B., Christen, B., Leung, D., & Vigo‐Pelfrey, C. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.2.370-376.1992 · Cited by 153 · see citing works
Schmidli, J., Hunziker, T., Moesli, P., & Schaad, U. B. (1988) · The Journal of Infectious Diseases · doi:10.1093/infdis/158.4.905 · Cited by 151 · see citing works
Häupl, T., Hahn, G., Rittig, M. G., Krause, A., Schoerner, C., Schönherr, U., Kalden, J. R., & Burmester, G. R. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780361118 · Cited by 143 · see citing works
Priem, S., Burmester, G. R., Kamradt, T., Wolbart, K., Rittig, M. G., & Krause, A. (1998) · Annals of the Rheumatic Diseases · doi:10.1136/ard.57.2.118 · Cited by 137 · see citing works
Characterization of Biofilm Formation by Borrelia burgdorferi In Vitro
Sapi, E., Bastian, S. L., Mpoy, C., Scott, S., Rattelle, A., Pabbati, N., Poruri, A., Burugu, D., Theophilus, P. A. S., Pham, T. V., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048277 · Cited by 135 · see citing works
Ackermann, R., Gollmer, E., & Rehse-Küpper, B. (2008) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-2008-1068956 · Cited by 133 · see citing works
Resurgence of Persisting Non-Cultivable Borrelia burgdorferi following Antibiotic Treatment in Mice
Hodzic, E., Imai, D. M., Feng, S., & Barthold, S. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086907 · Cited by 132 · see citing works
Intracellular persistence ofBorrelia burgdorferi in human synovial cells
Girschick, H. J., Huppertz, H., R�ssman, H., Krenn, V., & Karch, H. (1996) · Rheumatology International · doi:10.1007/bf01409985 · Cited by 128 · see citing works
Feng, J., Auwaerter, P. G., & Zhang, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117207 · Cited by 124 · see citing works
Suppression of Long-Lived Humoral Immunity Following Borrelia burgdorferi Infection
Elsner, R. A., Hastey, C. J., Olsen, K. J., & Baumgarth, N. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004976 · Cited by 117 · see citing works
Fibroblasts Protect the Lyme Disease Spirochete, Borrelia burgdorferi, from Ceftriaxone In Vitro
Georgilis, K., Peacocke, M., & Klempner, M. S. (1992) · The Journal of Infectious Diseases · doi:10.1093/infdis/166.2.440 · Cited by 116 · see citing works
Transformation of cystic forms ofBorrelia burgdorferi to normal, mobile spirochetes
Brorson, Ø., & Brorson, S. H. (1997) · Infection · doi:10.1007/bf01713153 · Cited by 115 · see citing works
Feng, J., Wang, T., Shi, W., Zhang, S., Sullivan, D. J., Auwaerter, P. G., & Zhang, Y. (2014) · Emerging Microbes & Infections · doi:10.1038/emi.2014.53 · Cited by 114 · see citing works
Feng, J., Wang, T., Zhang, S., Shi, W., & Zhang, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111809 · Cited by 110 · see citing works
Invasion of human neuronal and glial cells by an infectious strain of Borrelia burgdorferi
Livengood, J. A., & Gilmore, R. D. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2006.08.014 · Cited by 99 · see citing works
Dotevall, L., & Hagberg, L. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.7.1078 · Cited by 98 · see citing works
Stricker, R. B., & Sapi (2011) · Infection and Drug Resistance · doi:10.2147/idr.s19201 · Cited by 92 · see citing works
Formation and cultivation ofBorrelia burgdorferi spheroplast-L-form variants
Mursic, V. P., Reinhardt, S., Wilske, B., Busch, U., Wanner, G., & MARGET, W. (1996) · Infection · doi:10.1007/bf01781096 · Cited by 90 · see citing works
Clinical characteristics and prognostic markers in disulfiram-induced liver injury
Bjornsson, E. S., Nordlinder, H., & Olsson, R. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.12.016 · Cited by 82 · see citing works
Tetraethylthiuram disulfide (Antabuse) inhibits the human malaria parasite Plasmodium falciparum.
Scheibel, L. W., Adler, A., & Trager, W. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.10.5303 · Cited by 80 · see citing works
Evidence of in vivo existence of Borrelia biofilm in borrelial lymphocytomas
Sapi, E., Balasubramanian, K., Poruri, A., Maghsoudlou, J., Socarras, K. M., Timmaraju, V. A., Filush, K. R., Gupta, K., Shaikh, S., Theophilus, P. A. S., et al. (2016) · European Journal of Microbiology and Immunology · doi:10.1556/1886.2015.00049 · Cited by 75 · see citing works
Lesions of basal ganglia due to disulfiram neurotoxicity.
Laplane, D., Attal, N., Sauron, B., de Billy, A., & Dubois, B. (1992) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.10.925 · Cited by 74 · see citing works
Chronic progressive neurological involvement in Borrelia burgdorferi infection
Weder, B., Wiedersheim, P., Matter, L., Steck, A. J., & Otto, F. (1987) · Journal of Neurology · doi:10.1007/bf00314008 · Cited by 72 · see citing works
Long, T. E. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00898-17 · Cited by 67 · see citing works
Disulfiram-Induced Encephalopathy
Hotson, J. R., & Langston, J. W. (1976) · Archives of Neurology · doi:10.1001/archneur.1976.00500020069012 · Cited by 67 · see citing works
Embers, M. E., Hasenkampf, N. R., Jacobs, M. B., Tardo, A. C., Doyle‐Meyers, L. A., Philipp, M. T., & Hodzic, E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189071 · Cited by 67 · see citing works
Persistence of babesiosis for >2 years in a patient on rituximab for rheumatoid arthritis
Raffalli, J. T., & Wormser, G. P. (2016) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2016.02.016 · Cited by 63 · see citing works
Modern neurosyphilis: a partially treated chronic meningitis.
Hotson, J. R. (1981) · PubMed · Cited by 62 · see citing works
Liegner, K. B., Shapiro, J. R., Ramsay, D. L., Halperin, A. J., Hogrefe, W. R., & Kong, L. I. (1993) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(93)70043-s · Cited by 62 · see citing works
Self-citationTrypanocidal Activity of Antitumor Antibiotics and Other Metabolic Inhibitors
Williamson, J. S., & Scott-Finnigan, T. J. (1978) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.13.5.735 · Cited by 62 · see citing works
Seronegative Chronic Relapsing Neuroborreliosis
Lawrence, C., Lipton, R. B., Lowy, F. D., & Coyle, P. K. (2008) · European Neurology · doi:10.1159/000117104 · Cited by 60 · see citing works
Horita, Y., Takii, T., Yagi, T., Ogawa, K., Fujiwara, N., Inagaki, E., Kremer, L., Satô, Y., Kuroishi, R., Lee, Y., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06445-11 · Cited by 60 · see citing works
Structural Basis for Inactivation of Giardia lamblia Carbamate Kinase by Disulfiram
Galkin, A. G., Kulakova, L., Lim, K., Chen, C. Z., Zheng, W., Turko, I. V., & Herzberg, O. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.553123 · Cited by 59 · see citing works
Reinhardt, S., Stoye, N., Luderer, M., Kiefer, F., Schmitt, U., Lieb, K., & Endres, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-19577-7 · Cited by 58 · see citing works
Brorson, Ø., & Brorson, S.-H. (1999) · Apmis · doi:10.1111/j.1699-0463.1999.tb01594.x · Cited by 57 · see citing works
Identification of new drug candidates against Borrelia burgdorferi using high-throughput screening
Pothineni, V. R., Wagh, D. A., Babar, M. M., Inayathullah, M., Solow-Cordero, D. E., Kim, K., Samineni, A. V., Parekh, M. B., Tayebi, L., & Rajadas, J. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s101486 · Cited by 57 · see citing works
Manganese and Zinc Regulate Virulence Determinants in Borrelia burgdorferi
Troxell, B., Ye, M., Yang, Y., Carrasco, S. E., Lou, Y., & Yang, X. (2013) · Infection and Immunity · doi:10.1128/iai.00507-13 · Cited by 55 · see citing works
Feng, J., Zhang, S., Shi, W., Zubcevik, N., Judith Miklossy, A., & Zhang, Y. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00169 · Cited by 54 · see citing works
Theophilus, P. A. S., Victoria, M., Socarras, K. M., Filush, K. R., Gupta, K., Luecke, D. F., & Sapi, E. (2015) · European Journal of Microbiology and Immunology · doi:10.1556/1886.2015.00031 · Cited by 52 · see citing works
Macrolide therapy of chronic Lyme Disease.
Donta, S. T. (2003) · PubMed · Cited by 49 · see citing works
Chronic forms of Borrelia burgdorferi infection of the nervous system
Wokke, J. H. J., van Gijn, J., Elderson, A., & Stanek, G. (1987) · Neurology · doi:10.1212/wnl.37.6.1031 · Cited by 49 · see citing works
Treponemicidal Levels of Amoxicillin in Cerebrospinal Fluid After Oral Administration
Faber, W. R., Bos, J. D., Rietra, P. J. G. M., Fass, H., & van Eijk, R. V. W. (1983) · Sexually Transmitted Diseases · doi:10.1097/00007435-198307000-00011 · Cited by 48 · see citing works
Disulfiram-based disulfides as narrow-spectrum antibacterial agents
Sheppard, J. G., Frazier, K. R., Saralkar, P. A., Hossain, M. F., Geldenhuys, W. J., & Long, T. E. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.03.023 · Cited by 48 · see citing works
Embers, M. E., Barthold, S. W., Borda, J. T., Bowers, L. C., Doyle, L. A., Hodzic, E., Jacobs, M. B., Hasenkampf, N. R., Martin, D. S., Narasimhan, S., et al. (2012) · PLoS ONE · doi:10.1371/annotation/4cafed66-fb84-4589-a001-131d9c50aea6 · Cited by 48 · see citing works
Vyas, J. M., Telford, S. R., & Robbins, G. K. (2007) · Clinical Infectious Diseases · doi:10.1086/523731 · Cited by 47 · see citing works
Oral amoxycillin, an alternative treatment for neurosyphilis.
Morrison, R., HARRISON, S., & Tramont, E. C. (1985) · Sexually Transmitted Infections · doi:10.1136/sti.61.6.359 · Cited by 45 · see citing works
Johnson, D. J., Graham, D. G., Amarnath, K., Amarnath, K., & Valentine, W. M. (1996) · Chemical Research in Toxicology · doi:10.1021/tx960006v · Cited by 43 · see citing works
Ranek, L., & Andreasen, P. B. (1977) · BMJ · doi:10.1136/bmj.2.6079.94 · Cited by 42 · see citing works
Peripheral neuropathy after disulfiram administration
Gardner‐Thorpe, C., & Benjamin, S. (1971) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.34.3.253 · Cited by 41 · see citing works
Feng, J., Zhang, S., Shi, W., & Zhang, Y. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01744 · Cited by 40 · see citing works
The 93-kilodalton protein of Borrelia burgdorferi: an immunodominant protoplasmic cylinder antigen
Luft, B. J., Mudri, S., Jiang, W. B., Dattwyler, R. J., Gorevic, P. D., Fischer, T., Munoz, P., Dunn, J. J., & Schubach, W. H. (1992) · Infection and Immunity · doi:10.1128/iai.60.10.4309-4321.1992 · Cited by 39 · see citing works
Prevention of Lyme disease after tick bites.
Volkman, D. J., Kaell, A. T., Bosler, E. M., & Jl, B. (1993) · PubMed · Cited by 39 · see citing works
The Role of Pharmacotherapy in the Treatment of Adolescent Substance Use Disorders
Hammond, C. J. (2016) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2016.05.004 · Cited by 38 · see citing works
Feng, J., Weitner, M., Shi, W., Zhang, S., & Zhang, Y. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00062 · Cited by 36 · see citing works
Brorson, Ø., & Brorson, S.-H. (2004) · PubMed · Cited by 35 · see citing works
Chary-Valckenaere, I. (1998) · British journal of rheumatology · doi:10.1093/rheumatology/37.4.468 · Cited by 33 · see citing works
Distribution of S35 disulfiram and metabolites in mice, and metabolism of S35 disulfiram in the dog.
Faiman, Dodd, D. E., & Re, H. (1978) · PubMed · Cited by 32 · see citing works
Gilmore, R. D., Murphree, R. L., James, A. M., Sullivan, S. A., & Johnson, B. J. B. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.3.548-552.1999 · Cited by 30 · see citing works
The efficacy of artemisinin, artemether, and lumefantrine against Babesia gibsoni in vitro
Iguchi, A., Matsuu, A., Matsuyama, K., & Hikasa, Y. (2014) · Parasitology International · doi:10.1016/j.parint.2014.12.006 · Cited by 29 · see citing works
Bertrand, E., Gm, S., Piłkowska, E., Habib, N., Lipczyńska-Łojkowska, W., Rudnicka, A., Tylewska-Wierzbanowska, S., & Kulczycki, J. (1999) · PubMed · Cited by 29 · see citing works
Vulnerability to disulfiram psychosis.
Nasrallah, H. A. (1979) · PubMed · Cited by 27 · see citing works
Disulfiram neuropathy: two case reports
Tran, A. T., Rison, R. A., & Beydoun, S. R. (2016) · Journal of Medical Case Reports · doi:10.1186/s13256-016-0865-z · Cited by 25 · see citing works
Lyme disease: the sensible pursuit of answers
Liegner, K. B. (1993) · Journal of Clinical Microbiology · doi:10.1128/jcm.31.8.1961-1963.1993 · Cited by 23 · see citing works
Self-citationPothineni, V. R., Wagh, D. A., Inayathullah, M., Liu, S., Kim, K.-M., & Rajadas, J. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s77063 · Cited by 22 · see citing works
Disposition and Pharmacokinetics of Disulfiram and Calcium Carbimide (Calcium Cyanamide)
Brien, J. F., & Loomis, C. W. (1983) · Drug Metabolism Reviews · doi:10.3109/03602538308991384 · Cited by 22 · see citing works
Mohapatra, S., & Rath, N. R. (2017) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2017.15.1.68 · Cited by 21 · see citing works
Peniche, A. G., Renslo, A. R., Melby, P. C., & Travi, B. L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05131-14 · Cited by 21 · see citing works
Disulfiram-induced neuropathy: a case report
Mohapatra, S., Sahoo, M. R., & Rath, N. (2014) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2014.09.015 · Cited by 21 · see citing works
Nukada, H., & Pollock, M. (1981) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(81)90059-9 · Cited by 21 · see citing works
Fatal Liver Failure due to Disulfiram
Cereda, J., Bernuau, J., Degott, C., RUEFF, B., & Benhamou, J. (1989) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-198902000-00026 · Cited by 19 · see citing works
Disulfiram-Induced Hepatitis: Case Report and Review of the Literature
Mason, N. A. (1989) · DICP · doi:10.1177/106002808902301107 · Cited by 19 · see citing works
A Case of Psychosis in Disulfiram Treatment for Alcoholism
de Melo, R. C., Lopes, R., & Alves, J. C. (2014) · Case Reports in Psychiatry · doi:10.1155/2014/561092 · Cited by 17 · see citing works
[Recurrent and relapsing course of borreliosis of the nervous system].
Omasits, M., Seiser, A., & Brainin, M. (1990) · PubMed · Cited by 17 · see citing works
Screening of NCI-DTP library to identify new drug candidates for Borrelia burgdorferi
Pothineni, V. R., Wagh, D. A., Babar, M. M., Inayathullah, M., Watts, R. E., Kim, K., Parekh, M. B., Gurjarpadhye, A. A., Solow-Cordero, D. E., Tayebi, L., et al. (2016) · The Journal of Antibiotics · doi:10.1038/ja.2016.131 · Cited by 17 · see citing works
The Challenge of Intracellular Pathogens
Mahmoud, A. A. F. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203123261109 · Cited by 15 · see citing works
Watson, C. P., Ashby, P., & Bilbao, J. M. (1980) · Europe PMC (PubMed Central) · Cited by 15 · see citing works
(1990) · New England Journal of Medicine · doi:10.1056/nejm199002153220714 · Cited by 14 · see citing works
Verge, C. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i31.5078 · Cited by 13 · see citing works
Fulminant encephalopathy with unusual brain imaging in disulfiram toxicity
Peddawad, D., Nagendra, S., Chatterjee, R., Faldu, H. D., & Chheda, A. (2018) · Neurology · doi:10.1212/wnl.0000000000005125 · Cited by 13 · see citing works
Kulkarni, R. R., & Bairy, B. K. (2015) · Indian Journal of Psychological Medicine · doi:10.4103/0253-7176.162942 · Cited by 12 · see citing works
Disulfiram-induced hepatitis—report of a case and review of the literature
Nässberger, L. (1984) · Postgraduate Medical Journal · doi:10.1136/pgmj.60.707.639 · Cited by 12 · see citing works
Hochreiter, J. S., McCance‐Katz, E. F., Lapham, J., Ma, Q., & Morse, G. D. (2012) · Journal of Chromatography B · doi:10.1016/j.jchromb.2012.03.035 · Cited by 11 · see citing works
Basal Ganglia Infarction in a Child With Disulfiram Poisoning
Mahajan, P., Lieh-Lai, M. W., Sarnaik, A. P., & Kottamasu, S. R. (1997) · PEDIATRICS · doi:10.1542/peds.99.4.605 · Cited by 10 · see citing works
Fatal fulminant hepatic failure related to the use of disulfiram.
Watts, T. E., Pandey, R. A., & Vancil, T. J. (2014) · PubMed · Cited by 10 · see citing works
Santos, T., de Campos, A. M., & Morais, H. (2016) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2016.11.005 · Cited by 10 · see citing works
Disulfiram-induced seizures with convulsions in a young male patient: A case study
Jagadeesh, M., Vrishabhendraiah, S., Das, C. G., & Mruthyunjaya, N. (2015) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.166625 · Cited by 9 · see citing works
Disulfiram-Induced Reversible Hypertension: A Prospective Case Series and Review of The Literature
Kulkarni, R. R., Ramdurg, S. I., & Bairy, B. K. (2014) · Indian Journal of Psychological Medicine · doi:10.4103/0253-7176.140744 · Cited by 7 · see citing works
Disulfiram intoxication in a child
Benitz, W. E., & Tatro, D. S. (1984) · The Journal of Pediatrics · doi:10.1016/s0022-3476(84)80034-7 · Cited by 7 · see citing works
Liegner, K. B. (1992) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(08)80306-4 · Cited by 6 · see citing works
Self-citationSpirochetes in late seronegative syphili, despite penicillin therapy.
Jl, S. (1968) · PubMed · Cited by 6 · see citing works
Prevention of Lyme Disease after Tick Bites
Aronowitz, R. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301143280213 · Cited by 5 · see citing works
The use of antabus in the therapy of alcoholic patients.
MORIARTY, J. D. (1950) · PubMed · Cited by 4 · see citing works
Antimicrobial Prophylaxis after Tick Bites
Magid, D., Schwartz, B. S., Craft, J., & Schwartz, J. S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305133281910 · Cited by 4 · see citing works
Ferko, A. P. (1983) · PubMed · Cited by 1 · see citing works
Flagged first, then by citations
Research works printed but not linked: 6
- [6]Liegner K.B. Rosenkilde C. Campbell G. Quan T. Dennis D. Culture confirmed treatment failure of cefotaxime and minocycline in a case of Lyme meningoencephalomyelitis in the United States Proceedings of the Program and Abstracts of the 5th International Conference on Lyme Borreliosis Arlington, VA, USA 30 May–2 June 1992
- [16]Liegner K.B. Agricola M.D. Bayer M.E. Ph D. Chronic Lyme disease (CLD): A Costly Dilemma Proceedings of the Sixth International Conference on Lyme Borreliosis.Program and Abstracts Bologna, Italy 19–22 June 1994
- [41]In Vitro Effectiveness of Samento and Banderol Herbal Extracts on Different Morphological Forms of Borrelia Burgdorferi Available online: https://pdfs.semanticscholar.org/38d7/629dc0579b2fe178e783302aec5dd72d34c0.pdf?_ga=2.57626536.386697802.1559095302-1237682165.1549870465 (accessed on 16 December 2016)
- [42]Liegner K.B. Open-ended High Dose Long-acting Amoxicillin: An Alternative in the Treatment of Chronic and Neurologic Lyme Disease Proceedings of the 13th International Scientific Conference on Lyme Disease & Other Tick-Borne Disorders Farmington, CT, USA 25–26 March 2013
- [64]Liegner K.B. Ziska M. Agricola M.D. Hubbard J.D. Klempner M.S. Coyle P.K. Bayer M.E. Ph D. Fatal Chronic Meningoencephalo-myelitis (CMEM) With Massive Hydrocephalus, in A New York State Patient With Evidence Of Borrelia burgdorferi (Bb) Exposure Proceedings of the Sixth International Conference on Lyme Borreliosis Bologna, Italy 19–22 June 1994
- [65]Liegner K.B. Fatal progressive encephalitis following an untreated deer tick attachment in a 7 year-old Fairfield County, Connecticut child Proceedings of the International Conference on Lyme Disease and other Emerging Tick-Borne Diseases Munich, Germany 13–14 June 1999
Cited by
Sorted by citations
Disulfiram: Mechanisms, Applications, and Challenges
Lanz, J., Biniaz-Harris, N., Kuvaldina, M., Jain, S., Lewis, K., & Fallon, B. A. (2023) · Antibiotics · doi:10.3390/antibiotics12030524 · Cited by 125 · see citing works
The revival of dithiocarbamates: from pesticides to innovative medical treatments
Kaul, L., Süss, R., Zannettino, A. C. W., & Richter, K. (2021) · iScience · doi:10.1016/j.isci.2021.102092 · Cited by 98 · see citing works
Disulfiram: A novel repurposed drug for cancer therapy
Min De, Z. E. N. G., Wu, B., Wei, W., Jiang, Z., Li, P., Quan, Y., & Hu, X. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002909 · Cited by 64 · see citing works
Lyme Disease Frontiers: Reconciling Borrelia Biology and Clinical Conundrums
Bamm, V. V., Ko, J. T., Mainprize, I. L., Sanderson, V. P., & Wills, M. K. B. (2019) · Pathogens · doi:10.3390/pathogens8040299 · Cited by 47 · see citing works
Potula, H.-H. S. K., Shahryari, J., Inayathullah, M., Malkovskiy, A. V., Kim, K., & Rajadas, J. (2020) · Antibiotics · doi:10.3390/antibiotics9090633 · Cited by 33 · see citing works
A Class of Disulfide Compounds Suppresses Ferroptosis by Stabilizing GPX4
Liu, J.-P., Cen, S.-Y., Xue, Z., Wang, T.-X., Gao, Y., Zheng, J., Zhang, C., Hu, J., Nie, S., Xiong, Y., et al. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.2c00445 · Cited by 29 · see citing works
Omran, Z., Sheikh, R., Baothman, O. A., Zamzami, M. A., & Alarjah, M. (2020) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s254267 · Cited by 26 · see citing works
Custodio, M. M., Sparks, J., & Long, T. E. (2022) · Anti-Infective Agents · doi:10.2174/2211352520666220104104747 · Cited by 24 · see citing works
Solovieva, M. E., Shatalin, Y. V., Odinokova, I. V., Krestinina, O. V., Baburina, Y. L., Mishukov, A. A., Lomovskaya, Y. V., Pavlik, L., Mikheeva, I. B., Holmuhamedov, E., et al. (2022) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2022.130184 · Cited by 24 · see citing works
Gao, J., Gong, Z., Montesano, D., Glazer, E., & Liegner, K. (2020) · Antibiotics · doi:10.3390/antibiotics9120868 · Cited by 23 · see citing works
Self-citationScott, J. D., Clark, K. L., Coble, N. M., & Ballantyne, T. R. (2019) · Healthcare · doi:10.3390/healthcare7040155 · Cited by 22 · see citing works
Rudresha, G. V., Urs, A. P., Manjuprasanna, V. N., Gowda, M. D. M., Jayachandra, K., Rajaiah, R., & Vishwanath, B. S. (2021) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0008596 · Cited by 21 · see citing works
Álvarez-Manzo, H. S., Zhang, Y., Shi, W., & Zhang, Y. (2020) · Antibiotics · doi:10.3390/antibiotics9090542 · Cited by 16 · see citing works
Horowitz, R. I., & Freeman, P. R. (2020) · Antibiotics · doi:10.3390/antibiotics9110725 · Cited by 16 · see citing works
Synthesis and Biological Activity of Unsymmetrical Monoterpenylhetaryl Disulfides
Судариков, Д. В., Gyrdymova, Y. V., Борисов, А. В., Lukiyanova, J. M., Rumyantcev, R. V., Шевченко, О. Г., Baidamshina, D. R., Zakarova, N. D., Kayumov, A. R., Синегубова, E. O., et al. (2022) · Molecules · doi:10.3390/molecules27165101 · Cited by 15 · see citing works
Jiang, H., Zhao, Y., Tang, H., Duan, S., Li, M., Yang, X., Liu, J., Lou, X., Cai, Y., Zhao, W., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105923 · Cited by 12 · see citing works
Potential Patient-Reported Toxicities With Disulfiram Treatment in Late Disseminated Lyme Disease
Trautmann, A., Gascan, H., & Ghozzi, R. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00133 · Cited by 10 · see citing works
Horowitz, R. I., & Freeman, P. R. (2022) · Antibiotics · doi:10.3390/antibiotics11070912 · Cited by 8 · see citing works
A review of the therapeutic properties of dithiocarbamates
Tella, T., Pohl, C. H., & Ayangbenro, A. S. (2022) · F1000Research · doi:10.12688/f1000research.109553.1 · Cited by 7 · see citing works
Effect of Disulfiram on the Reproductive Capacity of Female Mice
Teng, M., Luo, Y., Wang, C., & Lei, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032371 · Cited by 5 · see citing works
Disulfiram—Mitigating Unintended Effects
Grout, M. M., & Mitchell, K. B. (2023) · Antibiotics · doi:10.3390/antibiotics12020262 · Cited by 5 · see citing works
Horowitz, R. I., Fallon, J., & Freeman, P. R. (2024) · Microorganisms · doi:10.3390/microorganisms12050909 · Cited by 3 · see citing works
Antabuse for Lyme Disease: The Way Forward
Younger, D. S., & Murphy, B. F. (2019) · World Journal of Neuroscience · doi:10.4236/wjns.2020.101001 · Cited by 3 · see citing works
Offutt, A., & Breitschwerdt, E. B. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1205545 · Cited by 2 · see citing works
Horowitz, R. I., Fallon, J., & Freeman, P. R. (2023) · Microorganisms · doi:10.3390/microorganisms11092301 · Cited by 3 · see citing works
Kuvaldina, M., Preston, J., McClellan, D., Pavlicova, M., Brannagan, T. H., & Fallon, B. A. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1549324 · Cited by 2 · see citing works
Ghobakhlou, F., Mokhtari, L., Pfeifer, T. A., & Paradis‐Bleau, C. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.09.648071 · Cited by 2 · see citing works
Benkő, B.-M., De Brito Parreirinha, N. S., Sebe, I., & Zelkó, R. (2026) · iScience · doi:10.1016/j.isci.2026.115441 · Cited by 2 · see citing works
Solovieva, M. E., Shatalin, Y. V., & Акатов, В. С. (2024) · Биологические мембраны Журнал мембранной и клеточной биологии · doi:10.31857/s0233475524030052 · Cited by 1 · see citing works
Benkő, B.-M., Szabó, B.-I., Kádár, S., Szabó, E., Tóth, G., Szente, L., Tonka-Nagy, P., Zelkó, R., & Sebe, I. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17070849 · Cited by 1 · see citing works
The Use of Natural Bioactive Nutraceuticals in the Management of Tick-Borne Illnesses
Shor, S. M., & Schweig, S. (2023) · Microorganisms · doi:10.3390/microorganisms11071759 · Cited by 1 · see citing works
(2019) · Reactions Weekly · doi:10.1007/s40278-019-65902-9
Das, A., Pathak, K., Pathak, M. P., Gogoi, U., & Saikia, R. (2024) · doi:10.1002/9781394188741.ch16
Solovieva, M. E., Shatalin, Y. V., & Акатов, В. С. (2024) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s1990747824700107
High-throughput LacZ/CPRG assay for identifying Gram-negative envelope-targeting antibiotics
Ghobakhlou, F., Mokhtari, L., Pfeifer, T. A., & Paradis‐Bleau, C. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1779546
- Authors
- Liegner, K. B.
- Affiliations
- Northern Westchester Hospital (US)
- Corresponding author
- Liegner, Kenneth B.
- Venue
- Antibiotics
- Publisher
- MDPI AG
- Published
- 2019-05-30
- Volume
- 8
- Issue
- 2
- Pages
- 72
- ISSN
- 2079-6382 (ISSN-L)
- PMC
- PMC6627205
- OpenAlex
- W2947236316
- Cited by
- 35
- References
- 118
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 5 · 2023: 6 · 2022: 6 · 2021: 3 · 2020: 6 · 2019: 4
- FWCI
- 3.66
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Antibiotics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Immunology and Microbiology › Parasitology › Vector-borne infectious diseases
- Health Sciences › Medicine › Physiology › Syphilis Diagnosis and Treatment
- Health Sciences › Veterinary › Small Animals › Brucella: diagnosis, epidemiology, treatment
- Keywords
- disulfiram, Lyme disease, babesiosis, antimicrobial therapy, treatment discontinuation, relapse
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
